pifithrin has been researched along with quinoxalines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SL; Chan, SS; Fiscus, RR; Fraser, M; Tsang, BK | 1 |
| Acharya, A; Chaudhari, U; Hengstler, JG; Hescheler, J; Nemade, H; Papadopoulos, S; Sachinidis, A | 1 |
2 other study(ies) available for pifithrin and quinoxalines
| Article | Year |
|---|---|
Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Topics: Adenoviridae; Apoptosis; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Benzothiazoles; Caspase 3; Caspases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Guanylate Cyclase; Half-Life; Humans; Mutation; Ovarian Neoplasms; Oxadiazoles; Phosphorylation; Proto-Oncogene Proteins c-mdm2; Quinoxalines; RNA, Small Interfering; Serine; Signal Transduction; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein | 2006 |
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.
Topics: Anthracyclines; Antineoplastic Agents; Apoptosis; Benzothiazoles; Calcium Channels; Calcium-Binding Proteins; Cell Death; Cells, Cultured; Cytoskeletal Proteins; Down-Regulation; Etoposide; Gene Expression; Humans; MicroRNAs; Mitochondria, Heart; Muscle Contraction; Myocytes, Cardiac; Pluripotent Stem Cells; Quinoxalines; Spiro Compounds; Toluene; Up-Regulation | 2018 |